Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1157 of 5804
-
Can a smartphone app keep heart attack patients out of the ER?
Disease control Not yet recruitingHeart attacks are one of the top causes of death in Canada, with over 2,100 cases treated each year in Manitoba. Even though hospital care has improved, the period after going home is still risky. Many patients feel anxious and unsure about their recovery, and without enough supp…
Phase: NA • Sponsor: St. Boniface Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:34 UTC
-
Shocking new hope: brain zaps may restore swallowing after stroke
Symptom relief Not yet recruitingIt is estimated that 400,000 to 800,000 people worldwide develop neurogenic dysphagia annually. Stroke represents the most common etiology, with approximately 65% of acute stroke patients experiencing pharyngeal swallowing difficulties. Clinical manifestations of dysphagia vary w…
Phase: NA • Sponsor: Zhejiang Provincial People's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New rabies vaccine could cut shots from three visits to one
⭐️ VACCINE ⭐️ Not yet recruitingThis is a phase II randomised, open-label study to assess the safety and immunogenicity of coadministration of the candidate rabies vaccine ChAdOx2 RabG and licensed vaccine in healthy adults (18-45 years old). ChAdOx2 RabG will be administered intramuscularly and licensed rabies…
Phase: PHASE2 • Sponsor: University of Oxford • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 07:57 UTC
-
Robot takes the wheel in heart surgery trial
Disease control Not yet recruitingThe goal of this clinical trial is to verify the safety and effectiveness of the vascular interventional robotic system developed and manufactured by Beijing Zhongke Hongtai Medical Technology Co., Ltd. in assisting percutaneous coronary intervention procedures in patients with c…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Stem cells take on Parkinson's: first safety trial begins
Disease control Not yet recruitingThis study, through different administration methods, adopted a randomized, double-blind, placebo-controlled trial design to evaluate the safety and tolerability of human umbilical cord mesenchymal stem cells (hUC-MSCs) in patients with Parkinson's disease, explore their initial …
Phase: PHASE1 • Sponsor: Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Mushroom compound may restore immune cells in cancer survivors
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the effectiveness of PRaG-1 in improving CD8+ lymphocytopenia in patients with solid tumors who are tumor-free for more than six months after completing radiotherapy and/or chemotherapy. It will also assess the safety of PRaG-1 Cordy…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Soochow University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New therapy aims to help psychosis patients quit cannabis
Disease control Not yet recruitingPeople suffering from psychosis who use cannabis experience more relapses, long and compulsory admissions, with huge costs to the individual, families and health services. The Cannabis Clinic for Psychosis (CCP) was developed to respond to this clinical need. A published review o…
Phase: NA • Sponsor: King's College London • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug aims to tame rare, Exercise-Triggered heart condition
Disease control Recruiting nowThis is a Phase 2, multicenter, double-blind, sponsor blinded, placebo-controlled, repeat-dose clinical study of CRD-4730 to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of CRD-4730 to participants with Catecholaminergic Polymorphic Ventricu…
Phase: PHASE2 • Sponsor: Cardurion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New sedative may cut delirium risk in elderly heart surgery patients
Symptom relief Not yet recruiting"Postoperative delirium is a common and serious complication following cardiac surgery, particularly among older adults who require intensive care. Its incidence is reported to range between 20% and 70% after cardiopulmonary bypass (CPB), and has been associated with prolonged ho…
Phase: PHASE4 • Sponsor: Yonsei University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New immunotherapy cocktail takes on stubborn colorectal cancer
Disease control Recruiting nowPhase 1b/2 open-label study evaluates the safety, tolerability, and efficacy of combination immunotherapy with nadunolimab (anti-IL-1RAP) and toripalimab (anti-PD-1) in patients with chemotherapy-refractory metastatic microsatellite stable (MSS) colorectal cancer. Phase 1b will a…
Phase: PHASE1, PHASE2 • Sponsor: Dan Feng • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Spit test could spot gum disease before It's too late
Diagnosis Not yet recruitingThis observational study aims to develop and validate a novel, AI-assisted electrochemical sensor platform for saliva-based diagnostics in periodontitis. Periodontitis is a chronic inflammatory disease affecting the gums and supporting tissues of the teeth. Despite its high globa…
Sponsor: Ostergotland County Council, Sweden • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
Laser light may replace steroids for chronic mouth pain
Disease control Recruiting nowThis study aims to compare three treatment approaches for the erosive form of oral lichen planus, a chronic inflammatory condition that often causes pain, impaired oral function, and frequent relapses. Sixty adults with a confirmed diagnosis will be randomly assigned to photobiom…
Phase: NA • Sponsor: Medical University of Silesia • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Heated chemo bath during stomach cancer surgery shows promise
Disease control Recruiting nowThe study investigates the outcomes of hyperthermic intraperitoneal chemoperfusion (HIPEC) in combination with curative-intent gastrectomy in resectable locally-advanced and limited-metastatic (low peritoneal cancer index) gastric cancer.
Sponsor: Ukrainian Society of Clinical Oncology • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Could a drink replace daily shots for growth hormone deficiency?
Disease control Not yet recruitingThis is a two-part clinical study for children with growth hormone deficiency. In the first part, participants will be randomly assigned to receive different doses of an oral treatment (GS3-007a dry suspension) or a placebo for 14 days. This part is double-blinded, meaning neithe…
Phase: PHASE1, PHASE2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Should liver cancer patients get surgery after drugs work? new study aims to find out
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to further explore the survival benefits of surgical resection after achieving CR in initial uHCC after systemic treatment and the timing of discontinuing systemic treatment
Sponsor: Fujian Provincial Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Smart radiation: daily adjustments may spare prostate cancer patients from side effects
Symptom relief Recruiting nowThis clinical trial studies the side effects of image-guidance and online adaptation with stereotactic body radiation therapy (SBRT) for the treatment of patients with prostate adenocarcinoma that has not spread to other parts of the body (localized). Image-guided SBRT is a stand…
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New hope for lymphoma patients: mosunetuzumab under review
Disease control Recruiting nowRetrospective, multicenter observational study to evaluate the response to treatment with Mosunetuzumab in relapsed/refractory Follicular Lymphoma (FL) after at least three lines of therapy, within the Compassionate Use Program (CUP).
Sponsor: Andrés José Maria Ferreri • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New bead therapy may improve liver cancer treatment after shunt procedure
Disease control Recruiting nowThis is a Phase 3, open-label, multicenter, randomized controlled clinical trial designed to evaluate the efficacy and safety of Drug-Eluting Bead Transarterial Chemoembolization (DEB-TACE) compared with Conventional Transarterial Chemoembolization (cTACE) in patients with hepato…
Phase: PHASE3 • Sponsor: First Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Music and fun activities may speed up stroke rehab
Symptom relief Recruiting nowThe goal of this clinical trial is to learn whether adding group leisure activities and musical training can help people recover better after a stroke during their hospital rehabilitation. The study will include adults who had a recent stroke and are staying in the neurological r…
Phase: NA • Sponsor: Escola Universitària d'Infermeria i Teràpia Ocupacional de Terrassa • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Could a magnesium supplement boost sleep and brainpower under fatigue?
Symptom relief CompletedThis study examined the effects of six weeks of magnesium L-threonate (MgT) supplementation on sleep quality, cognitive performance under experimentally induced mental fatigue, neuromuscular function, and psychophysiological outcomes in healthy adults. Biological sex and weight s…
Phase: NA • Sponsor: Barry University • Aim: Symptom relief
Last updated Jul 17, 2026 00:00 UTC